Bryan D. Hayes, PharmD, is participating in a workgroup convened by the American Academy of Clinical Toxicology to discuss and clarify the clinic applications of intravenous lipid therapy. Lipid emulsion has been used for about 10 years to counter cardiovascular collapse induced by local and regional anesthetics and, more recently, in the management of overdoses of lipophilic drugs. The purpose of the workgroup is to review the relevant medical literature and then develop evidence-based clinical guidelines. The structure and strategy of the group are described in the July issue of Clinical Toxicology (2015;53[6]:557‒564).
Blog Archives
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012